Abstract:Emerging evidence suggests that GSK3β, a redox-sensitive transducer downstream of insulin signaling, acts as a convergent point for myriad pathways implicated in kidney injury, repair, and regeneration. However, its role in diabetic kidney disease remains controversial. In cultured glomerular podocytes, exposure to a milieu of type 2 diabetes elicited prominent signs of podocyte injury and degeneration, marked by loss of homeostatic marker proteins like synaptopodin, actin cytoskeleton disruption, oxidative stress and apoptosis, and stress-induced premature senescence, as shown by increased staining for senescence-associated β-galactosidase activity, amplified formation of γH2AX foci, and elevated expression of mediators of senescence signaling, like p21 and p16INK4A. These degenerative changes coincided with GSK3β hyperactivity, as evidenced by GSK3β overexpression and reduced inhibitory phosphorylation of GSK3β, and were averted by tideglusib, a highly-selective small molecule inhibitor of GSK3β. In agreement, post-hoc analysis of a publicly-available glomerular transcriptomics dataset from patients with type 2 diabetic nephropathy revealed that the curated diabetic nephropathy-related gene set was enriched in high GSK3β expression group. Mechanistically, GSK3β-modulated nuclear factor Nrf2 signaling is involved in diabetic podocytopathy, because GSK3β knockdown reinforced Nrf2 antioxidant response and suppressed oxidative stress, resulting in an improvement in podocyte injury and senescence. Conversely, ectopic expression of the constitutively active mutant of GSK3β impaired Nrf2 antioxidant response and augmented oxidative stress, culminating in an exacerbated diabetic podocyte injury and senescence. Moreover, IRS-1 was found to be a cognate substrate of GSK3β for phosphorylation at IRS-1S332, which negatively regulates IRS-1 activity. GSK3β hyperactivity promoted IRS-1 phosphorylation, denoting a desensitized insulin signaling. Consistently, in vivo in db/db mice with diabetic nephropathy, GSK3β was hyperactive in glomerular podocytes, associated with IRS-1 hyperphosphorylation, impaired Nrf2 response and premature senescence. Our finding suggests that GSK3β is likely a novel therapeutic target for treating type 2 diabetic glomerular injury.

Protein S Protects against Podocyte Injury in Diabetic Nephropathy

Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.

Diosgenin Protects Against Podocyte Injury in Early Phase of Diabetic Nephropathy Through Regulating SIRT6.

Emerging Protective Actions of PGC-1α in Diabetic Nephropathy

TNF-? and IL-1? Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters

The Redox-Sensitive GSK3β is a Key Regulator of Glomerular Podocyte Injury in Type 2 Diabetic Kidney Disease

Podocyte SIRPα Reduction in Diabetic Nephropathy Aggravates Podocyte Injury by Promoting Pyruvate Kinase M2 Nuclear Translocation

Tyro3 is a podocyte protective factor in glomerular disease

Dissection of Glomerular Transcriptional Profile in Patients with Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function.

Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects

Regulation of the Homeostatic Unfolded Protein Response in Diabetic Nephropathy

Role and Mechanisms of Tyro3 in podocyte biology and glomerular disease

Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease

Panax Notoginseng Ameliorates Podocyte EMT by Targeting the Wnt/β-Catenin Signaling Pathway in STZ-Induced Diabetic Rats

Xuesaitong Protects Podocytes from Apoptosis in Diabetic Rats Through Modulating PTEN-PDK1-Akt-mTOR Pathway.

Deposition of Platelet-Derived Microparticles in Podocytes Contributes to Diabetic Nephropathy

Ginsenoside Rg1 Alleviates Podocyte Injury Induced by Hyperlipidemia Via Targeting the Mtor/nf-Κb/nlrp3 Axis.

Research progress of natural active compounds on improving podocyte function to reduce proteinuria in diabetic kidney disease

Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway

Vitamin D Receptor Signaling in Podocytes Protects Against Diabetic Nephropathy.

ER Stress-Perturbed Intracellular Protein O-GlcNAcylation Aggravates Podocyte Injury in Diabetes Nephropathy